Skip to main content
Photocure ASA logo

Photocure ASA — Investor Relations & Filings

Ticker · PHO ISIN · NO0010000045 LEI · 5967007LIEEXZXG8OW35 OL Manufacturing
Open in API
Filings indexed 1,320 across all filing types
Latest filing 2022-06-01 Director's Dealing
Country NO Norway
Listing OL PHO

About Photocure ASA

https://www.photocure.com/

Photocure is a specialty pharmaceutical company focused on bladder cancer. It develops and commercializes products and medical devices based on proprietary photodynamic technology. The company's primary offering is Blue Light Cystoscopy (BLC) with its imaging agents, Hexvix®/Cysview®, which is used for the improved detection and management of bladder cancer. Photocure aims to deliver transformative solutions to the urologic oncology community to improve patient outcomes. The company is also engaged in developing advanced diagnostic technologies, including the integration of artificial intelligence with its BLC systems.

Recent filings

Filing Released Lang Actions
Photocure ASA: Exercise of employee share options and share capital increase
Director's Dealing Classification · 98% confidence The document is titled "NOTIFICATION OF TRANSACTIONS PURSUANT TO THE MARKET ABUSE REGULATION ARTICLE 19". This regulation mandates that persons discharging managerial responsibilities (PDMRs) must notify the issuer and the relevant national competent authority of transactions conducted on their own account relating to the shares or debt instruments of that issuer. The content details transactions (exercise of share options) by individuals identified as 'Person discharging managerial responsibilities' (CEO and CFO) of PHOTOCURE ASA. This specific type of insider transaction reporting aligns directly with the definition of Director's Dealing (DIRS), which covers personal share transactions by directors and executives (insider trades). It is not a general earnings release (ER), a full annual report (10-K), or a proxy statement (DEF 14A/PSI).
2022-06-01 English
Photocure ASA: Exercise of employee share options and share capital increase
Share Issue/Capital Change Classification · 98% confidence The document explicitly details the exercise of employee share options, the subsequent increase in share capital, and the issuance of new shares. It also mentions transactions by primary insiders (CEO and CFO) related to these shares. This activity directly relates to changes in the company's capital structure and share count. Based on the definitions, 'Share Issue/Capital Change' (SHA) is the most appropriate category, as it covers new share issues and capital structure changes resulting from option exercises. While Director's Dealing (DIRS) is mentioned regarding insider transactions, the primary focus and action described is the capital increase resulting from the option exercise, making SHA the better fit. It is not a general regulatory filing (RNS) because it fits a specific category.
2022-06-01 English
Photocure ASA: Exercise of employee share options and share capital increase
Share Issue/Capital Change Classification · 99% confidence The document explicitly details the exercise of employee share options, the resulting increase in share capital, and the issuance of new shares. It also mentions transactions by primary insiders (CEO and CFO) and references MAR Article 19 notifications, which are related to insider dealings and capital changes. The core subject is the change in the company's share structure due to option exercises and capital increase. This aligns best with the 'Share Issue/Capital Change' category (SHA). While it involves insider transactions (DIRS), the primary corporate action being announced is the capital change resulting from the option exercise.
2022-06-01 English
Photocure ASA - Initiation of a share buyback
Transaction in Own Shares Classification · 100% confidence The document explicitly announces the 'Initiation of a share buyback' by Photocure ASA. It details the maximum number of shares (36,000) and the maximum amount (NOK 9,000,000) to be repurchased, the purpose (settlement in incentive schemes, capital reduction), and the execution period. This directly corresponds to the definition of 'Transaction in Own Shares' (POS), which covers share repurchase programs.
2022-06-01 English
Photocure ASA - Initiation of a share buyback
Transaction in Own Shares Classification · 100% confidence The document explicitly states its purpose: 'Photocure ASA - Initiation of a share buyback'. It details the maximum number of shares to be repurchased (up to 36,000), the maximum amount (NOK 9,000,000), the period for execution, and the rationale (settlement in incentive schemes or capital reduction). This directly corresponds to the definition of 'Transaction in Own Shares' (POS), which covers share repurchase programs.
2022-06-01 English
Blue Light Cystoscopy continues to make news at AUA 2022
Regulatory Filings Classification · 100% confidence The document is explicitly titled 'Press Release' and details company activities, product news (Blue Light Cystoscopy), and participation in a conference (AUA 2022). It includes quotes from management, information about the company's product, and contact details for media/investor relations. This structure is characteristic of an Earnings Release (ER) or a general corporate announcement. Since it is not a full financial report (like 10-K or IR) but rather an announcement of business updates and conference participation, 'ER' (Earnings Release) is the closest fit among the options for a significant corporate update, although 'RNS' (Regulatory Filings) is also plausible for non-standard announcements. Given the content focuses on recent business developments and conference highlights, ER is selected as the primary classification for a major corporate update, even if it's not strictly tied to quarterly earnings figures in this snippet.
2022-05-18 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.